What to know about Zurzuvae, the new pill to treat postpartum depression
The FDA recently approved zuranolone, the first-ever oral medication to treat postpartum depression. A Yale psychiatrist answers questions about the new drug.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Depression | Health | Postnatal Depression | Psychiatry | Science | Universities & Medical Training | Yale